Argent Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.18M Buy
36,755
+987
+3% +$94.6K 0.87% 30
2025
Q4
$3.44M Sell
35,768
-164
-0.5% -$15.9K 0.96% 29
2025
Q3
$3.42M Buy
35,932
+1,337
+4% +$123K 1.01% 25
2025
Q2
$3.02M Buy
34,595
+1,932
+6% +$164K 0.93% 25
2025
Q1
$2.94M Buy
32,663
+2,946
+10% +$264K 0.98% 25
2024
Q4
$2.37M Buy
29,717
+820
+3% +$71K 0.88% 28
2024
Q3
$2.6M Buy
28,897
+569
+2% +$47.9K 0.97% 25
2024
Q2
$2.23M Buy
28,328
+1,199
+4% +$98.3K 0.89% 24
2024
Q1
$2.36M Buy
27,129
+808
+3% +$69K 0.94% 24
2023
Q4
$2.17M Buy
26,321
+434
+2% +$33.1K 0.95% 23
2023
Q3
$2.03M Buy
25,887
+1,405
+6% +$118K 0.93% 23
2023
Q2
$2.16M Buy
24,482
+1,527
+7% +$131K 0.99% 20
2023
Q1
$1.85M Buy
22,955
+6,219
+37% +$507K 0.88% 23
2022
Q4
$1.3M Sell
16,736
-402
-2% -$32.6K 0.67% 43
2022
Q3
$1.38M Buy
17,138
+10,215
+148% +$918K 0.81% 31
2022
Q2
$621K Buy
6,923
+1,159
+20% +$117K 0.35% 73
2022
Q1
$640K Buy
+5,764
New +$609K 0.34% 81

Other funds holding MDT

Argent Advisors's MDT Position: Q1 2026 in Review

Argent Advisors increased its Medtronic (MDT) stake by 2.8% in Q1 2026, buying an estimated $94.6K and bringing the position to 36,755 shares worth $3.18M. The position accounts for 0.87% of the portfolio, ranked #30.

Argent Advisors first reported a position in MDT in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.44M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Argent Advisors held 36,755 shares of Medtronic worth $3.18M as of Q1 2026.
  • Argent Advisors bought 987 Medtronic shares in Q1 2026, an estimated $94.6K.
  • Medtronic made up 0.87% of Argent Advisors's portfolio in Q1 2026, its #30 holding.
  • Argent Advisors first reported a position in Medtronic in Q1 2022 and has held it in 17 quarters since.
  • Argent Advisors's Medtronic position peaked at $3.44M in Q4 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Argent Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.